BPC?157 is a stable synthetic peptide fragment derived from human gastric juice protein. Unlike many easily degraded endogenous peptides, this short peptide exhibits notable resistance against protease breakdown in biological environments, which makes it widely selected for preclinical tissue recovery related exploration.

Current laboratory research mainly focuses on its regulatory effects on cellular migration, angiogenesis and inflammatory response modulation. Research models cover multiple tissue injury scenarios, including gastrointestinal mucosal damage, tendon and ligament injury, as well as vascular repair mechanism exploration. It serves as a valuable research tool for studying inflammatory signalling and tissue regeneration pathways at cellular and animal levels.

It is produced via solid-phase peptide synthesis and undergoes multiple rounds of reversed-phase chromatographic purification before freeze-drying treatment. The lyophilized form minimizes peptide hydrolysis during storage. Once reconstituted, aliquot the liquid into separate single-use vials. Frequent freezing and thawing will gradually degrade peptide chains and reduce bioactivity. Handle the powder in low-humidity surroundings to prevent moisture absorption.